During the past decade, I.R.C.C. - Unit of Medical Oncology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "I.R.C.C. - Unit of Medical Oncology" #1 collaborator was "PharmaMar" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "I.R.C.C. - Unit of Medical Oncology" are "Osteosarcoma" (2 trials), "Advanced Chondrosarcoma" (1 trials), "Advanced Desmoid Tumor" (1 trials), "Ewing Sarcoma of Bone" (1 trials) and "Ewing's Sarcoma" (1 trials). Many other conditions were trialed in "I.R.C.C. - Unit of Medical Oncology" in a lesser frequency.

Most popular intervention types in "I.R.C.C. - Unit of Medical Oncology" are "Drug" (7 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Trabectedin" (2 trials), "3 drugs arm" (1 trials), "ADM" (1 trials), "BUMEL" (1 trials) and "CYC" (1 trials). Other intervention names were less common.

The vast majority of trials in "I.R.C.C. - Unit of Medical Oncology" are 8 trials for "All" genders.

Currently, there are NaN active trials in "I.R.C.C. - Unit of Medical Oncology". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in I.R.C.C. - Unit of Medical Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in I.R.C.C. - Unit of Medical Oncology, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".